Clinical Trials Directory

Trials / Sponsors / Bionorica SE

Bionorica SE

Industry · 13 registered clinical trials.

StatusTrialPhaseStarted
CompletedEfficacy of Vitex Agnus-castus BNO 1095 (20 mg) in Women With Primary Dysmenorrhea
Primary Dysmenorrhea
Phase 32023-12-12
UnknownSkin Efficacy and Tolerability of a Cosmetic Product Combination Over 3 Months in Subjects With Atopic Eczema
Atopic Dermatitis, Eczema-Prone Skin
N/A2023-01-03
CompletedAssessment of Skin Tolerance and Efficacy of a Cosmetic Product After 5 Days of Use on Subjects With Atopic De
Atopic Diathesis, Eczema-prone Skin
N/A2022-02-15
CompletedAssessment of Skin Tolerance and Efficacy of a Cosmetic Product After 4 Weeks of Use on Subjects With Atopic D
Atopic Diathesis, Eczema-Prone Skin
N/A2022-01-11
CompletedBX-1 in Spasticity Due to Multiple Sclerosis
Spasticity Due to Multiple Sclerosis
Phase 32019-02-18
CompletedSinupret Extract Coated Tablets in Chronic Rhinosinusitis
Chronic Rhinosinusitis
Phase 32016-04-28
CompletedEfficacy of CLR Compared to Fosfomycin Trometamol in Acute Lower uUTIs
Urinary Tract Infection
Phase 32015-12-01
CompletedTrial With Bronchipret and Sinupret to Evaluate Acceleration of Mucociliary Clearance (MCC)
Current Smokers
Phase 22013-08-01
TerminatedEfficacy and Safety of 20 mg (2 Tablets of 10mg)VAC BNO 1095 FCT on Cyclic Mastodynia and PMS
Premenstrual Syndrome, Mastodynia
Phase 32013-06-01
CompletedEfficacy and Safety of Two Dosages of a Herbal Medicinal Product (Dry Extract BNO 1016) in Chronic Rhinosinusi
Chronic Sinusitis
Phase 32012-09-01
CompletedSafety and Efficacy of Canephron® N in the Management of Uncomplicated Urinary Tract Infections (uUTI)
Urinary Tract Infection
Phase 32011-10-01
CompletedDose-dependent Effects of VAC BNO 1095 on Cyclic Mastodynia and Premenstrual Syndrome
Cyclic Mastodynia, Premenstrual Syndrome
Phase 32011-03-01
CompletedEfficacy and Safety of a Herbal Medicinal Product (Dry Extract BNO 1016) in Patients With Acute Rhinosinusitis
Acute Rhinosinusitis
Phase 32010-01-01